Nostrilla
NDC 63736-730, Oxymetazoline Hydrochloride, spray, metered, from Insight Pharmaceuticals LLC.
- Product NDC
- 63736-730
- Status
- Listed
- Labeler
- Insight Pharmaceuticals LLC
- Dosage form
- SPRAY, METERED
- Route
- NASAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63736-730 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYMETAZOLINE HYDROCHLORIDE.05 mg/100mL
Pharmacologic classes
Imidazolines [CS]; Increased Sympathetic Activity [PE]; Vasoconstriction [PE]; Vasoconstrictor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63736-730-01 | 63736073001 | 1 BOTTLE, SPRAY in 1 CARTON (63736-730-01) / 15 mL in 1 BOTTLE, SPRAY |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63736-730 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63736-730 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63736-730. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.